BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25860580)

  • 1. [Langerhans cell histiocytosis of the stomach with BRAF-V600E-mutation: case report and review of the literature].
    Sarbia M; Mauerer R; Bettstetter M; Funk A
    Z Gastroenterol; 2015 Apr; 53(4):302-5. PubMed ID: 25860580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cell histiocytosis involving the gastrointestinal tract.
    Behdad A; Owens SR
    Arch Pathol Lab Med; 2014 Oct; 138(10):1350-2. PubMed ID: 25268199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Langerhans cell histiocytosis of the thymus with BRAF V600E mutation: a case report with immunohistochemical and genetic analyses.
    Oishi N; Kondo T; Mochizuki K; Inoue T; Kasai K; Nakazawa T; Mitsumori T; Katoh R
    Hum Pathol; 2014 Jun; 45(6):1302-5. PubMed ID: 24703101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
    A Al Hamad M; Albisher HM; Al Saeed WR; Almumtin AT; Allabbad FM; A Shawarby M
    BMC Cancer; 2019 Feb; 19(1):170. PubMed ID: 30795755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of BRAF
    Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
    Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.
    Méhes G; Irsai G; Bedekovics J; Beke L; Fazakas F; Rózsa T; Kiss C
    Am J Surg Pathol; 2014 Dec; 38(12):1644-8. PubMed ID: 25118810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.
    Roden AC; Hu X; Kip S; Parrilla Castellar ER; Rumilla KM; Vrana JA; Vassallo R; Ryu JH; Yi ES
    Am J Surg Pathol; 2014 Apr; 38(4):548-51. PubMed ID: 24625419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between clinicopathologic characteristics and BRAF
    Huang H; Lu T; Sun Y; Li S; Li J; Xu K; Feng RE; Xu ZJ
    Thorac Cancer; 2019 Oct; 10(10):1984-1992. PubMed ID: 31441596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular morphology of BRAF V600E-positive Langerhans cell histiocytosis.
    Satpathy AT; Tan BT
    Blood; 2015 Oct; 126(15):1857. PubMed ID: 26734696
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
    Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
    Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and BRAF
    Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
    Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Pulmonary Langerhans Cell Histiocytosis with BRAF V600E-negative and MAP2K1-posivtive Mutations Presenting as Diffuse Nodules in Chest High-resolution Computed Tomography After Smoking Cessation.
    Li Y; Cai HR; Ma M; Wang LJ; Yang J; Ding JJ; Miao LY
    Chin Med J (Engl); 2016 Jun; 129(11):1384-6. PubMed ID: 27231182
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating cell-free BRAF
    Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
    Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper Gastrointestinal Langerhans Cell Histiocytosis: A Report of 2 Adult Cases and a Literature Review.
    Matsuoka Y; Iemura Y; Fujimoto M; Shibuya S; Yamada A; Fujii S; Kusaka T; Shindo T; Minamiguchi S; Haga H
    Int J Surg Pathol; 2021 Aug; 29(5):550-556. PubMed ID: 33034230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.
    Dimmler A; Geddert H; Werner M; Faller G
    Virchows Arch; 2017 Apr; 470(4):429-435. PubMed ID: 28220299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.
    Charles J; Beani JC; Fiandrino G; Busser B
    J Am Acad Dermatol; 2014 Sep; 71(3):e97-9. PubMed ID: 25128147
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-existence of BRAF V600E-mutated malignant melanoma and BRAF V600E-mutated Langerhans cell histiocytosis: A case report.
    Goto K; Yoshikawa S; Kiyohara Y; Kukita Y; Miura K; Oishi T
    J Cutan Pathol; 2022 Apr; 49(4):393-398. PubMed ID: 34792818
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ozer E; Sevinc A; Ince D; Yuzuguldu R; Olgun N
    Pediatr Dev Pathol; 2019 Oct; 22(5):449-455. PubMed ID: 31072207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging diagnosis of two neoplasms, Langerhans cell histiocytosis and papillary thyroid carcinoma, from fine needle aspiration of the thyroid by cell-block immunocytochemistry and molecular testing for BRAF V600E mutation.
    Zaidi A; Gautam U; Srinivasan R; Bal A; Prakash G; Sood A
    Cytopathology; 2020 Nov; 31(6):598-601. PubMed ID: 32150778
    [No Abstract]   [Full Text] [Related]  

  • 20. High Prevalence of
    Liu X; Zhang Y; Zhou CX
    Int J Surg Pathol; 2019 Dec; 27(8):836-843. PubMed ID: 31203679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.